Trofosfamide Versus Adriamycin in Elderly Patients With Soft Tissue Sarcoma (STS)
Status:
Unknown status
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
The goal of this trial is to determine whether oral continuous (metronomic) therapy with
trofosfamide results in a similar rate of progression-free time after 6 months as intravenous
treatment with adriamycin. In addition, the study is intended to investigate the level of
toxicity associated with the two treatment regimens (safety profile).
Phase:
Phase 2
Details
Lead Sponsor:
University Hospital Schleswig-Holstein University of Schleswig-Holstein
Collaborators:
Arbeitsgemeinschaft fur Internistische Onkologie French Sarcoma Group German Sarcoma Group